| 申请日期 | 2025-07-23 | 申请号 | CA2694266 |
| 公开（公告）号 | CA2694266A1 | 公开（公告）日 | 2008-12-31 |
| 公开国别 | CA | 申请人省市代码 | 全国 |
| 申请人 | THE JOHNS HOPKINS UNIVERSITY | ||
| 简介 | The prostate-specific membrane antigen (PSMA) is increasingly recognized as a viable target for imaging and therapy of cancer. Various 99mTc/Re-labeled compounds were prepared by attaching known Tc/Re chelating agents to an amino--functionalized PSMA inhibitor with or without a variable length linker moiety. Ex vivo biodistribution and in vivo imaging demonstrated the degree of specific binding to engineered PSMA+ PC3 PIP tumors. | ||
|
您还没有登录，请登录后查看下载地址
|
客服热线：
手机版
二维码
